Article
Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms.
Mediators of inflammation - 1 Jan 2015
Čokić Vladan P, Mitrović-Ajtić Olivera, Beleslin-Čokić Bojana B, Marković Dragana, Buač Marijana, Diklić Miloš, Kraguljac-Kurtović Nada, Damjanović Svetozar, Milenković Pavle, Gotić Mirjana, Raj Puri K
Abstract excerpt
The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflammation can be more beneficial than targeting gene mutants. We evaluated the proinflammatory IL-6 cytokine and JAK-STAT signaling pathway related genes in circulating CD34(+) cells of MPNs. Regarding laboratory data, leukocytosis has been observed in polycythemia vera (PV) and JAK2V617F mutation positive versus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
